Shares of Indivior PLC (LON:INDV) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $58.36 and traded as high as $55.12. Indivior shares last traded at $53.70, with a volume of 1,535,189 shares.
The company has a market cap of $392.40 million and a P/E ratio of 1.58. The company has a quick ratio of 1.86, a current ratio of 1.97 and a debt-to-equity ratio of 143.90. The business has a 50-day moving average price of GBX 58.39 and a two-hundred day moving average price of GBX 61.44.
In other news, insider Peter Bains bought 54,000 shares of the company’s stock in a transaction dated Thursday, August 8th. The stock was bought at an average price of GBX 61 ($0.80) per share, for a total transaction of £32,940 ($43,041.94).
About Indivior (LON:INDV)
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.
Featured Article: What is the Beige Book?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.